When it comes to developing a compound, the 505(b)(2) drug development pathway is not just a regulatory platform — it’s a different animal. This pathway offers a holistic approach for developing products that offer differentiated benefits with Lower Risk, Reduced Cost and Faster Speed to Market.
From concept through commercialization, Camargo is your full-service drug development partner specializing in the 505(b)(2) process. Learn more about 505(b)(2) by downloading our white paper.
P.S. We’ll be at the DIA Annual Meeting, booth #410 — schedule a meeting with our experts.